Cloning of the promoter region of the CISH gene into the improved pGL4.10 luciferase reporter construct resulted in a highly sensitive, PRL-responsive reporter that should be of widespread utility in examining PRL/Stat5 pathway in ER+ human breast cancer cells. This evidence concerns the gene CISH and breast carcinoma.